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Summary
Since little is known about chromosomal locations har-
boring type 2 diabetes–susceptibility genes, we con-
ducted a genomewide scan for such genes in a Mexican
American population. We used data from 27 low-income
extended Mexican American pedigrees consisting of
440 individuals for whom genotypic data are available
for 379 markers. We used a variance-components tech-
nique to conduct multipoint linkage analyses for two
phenotypes: type 2 diabetes (a discrete trait) and age at
onset of diabetes (a truncated quantitative trait). For the
multipoint analyses, a subset of 295 markers was se-
lected on the basis of optimal spacing and informative-
ness. We found significant evidence that a susceptibility
locus near the marker D10S587 on chromosome 10q
influences age at onset of diabetes (LOD score 3.75) and
is also linked with type 2 diabetes itself (LOD score
2.88). This susceptibility locus explains 63.8%
( ) of the total phenotypic variation9.9% P  .000016
in age at onset of diabetes and (65.7% 10.9% P 
) of the total variation in liability to type 2 di-.000135
abetes. Weaker evidence was found for linkage of dia-
betes and of age at onset to regions on chromosomes
3p, 4q, and 9p. In conclusion, our strongest evidence
for linkage to both age at onset of diabetes and type 2
diabetes itself in the Mexican American population was
for a region on chromosome 10q.
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Introduction
Type 2 diabetes mellitus is a complex blood glu-
cose–homeostasis disorder characterized by both insulin
resistance and pancreatic b-cell dysfunction (Rewers and
Hamman 1995; Polonsky et al. 1996). The belief that
type 2 diabetes has strong genetic determinants is based
on several lines of evidence, including the high rate of
concordance among MZ twins (Barnett et al. 1981;
Newman et al. 1987), the marked disease-rate differ-
ences between populations (Zimmet 1979; Diehl and
Stern 1989; McKeigue et al. 1991), and the close cor-
respondence, in hybrid populations, between genetic ad-
mixture rates and disease prevalence (Brosseau et al.
1979; Chakraborty et al. 1986; Knowler et al. 1988).
In addition, there is evidence for major gene(s) influ-
encing diabetes or its related phenotypes, such as glucose
concentrations, 2-h insulin levels, and age at onset of
diabetes (Elston et al. 1974; Serjeantson and Zimmet
1984; Hanson et al. 1995; Mitchell et al. 1995; Stern et
al. 1996b). However, the mode of inheritance for type
2 diabetes appears to be variable across populations,
suggesting a complex genetic architecture underlying this
disease.
Since a number of genes are involved in the pathways
of insulin action and glucose-stimulated insulin secre-
tion, any genetic defect in these pathways might con-
tribute to type 2 diabetes (Pillay et al. 1995; Kahn et al.
1996). Numerous studies are in progress that are ex-
amining the possible roles of such candidate genes in
diabetes. However, the genes thus far examined appear
to account for a very small proportion of the suscepti-
bility to type 2 diabetes, and significant findings in some
populations often fail to be replicated in others (Elbein
1997). It is unclear to what extent inconsistent results
across populations could be due to factors such as dif-
ferent study designs (sib pairs, extended pedigrees, etc.),
sample size, choice or power of the analytical methods
(affected-sib-pair–based methods, variance-components
approaches, etc.) or to genuine heterogeneity of the dis-
ease itself (McCarthy et al. 1994; Ghosh and Schork
1996; Elbein 1997).
1128 Am. J. Hum. Genet. 64:1127–1140, 1999
Table 1
Numbers and Types of Relative Pairs in a Subset of SAFADS Families in the
Present Study, Including 440 Individuals Distributed across 27 Pedigrees
TYPE OF RELATIVE PAIR
RELATIONSHIP
COEFFICIENTa
NO. OF
U-U U-A A-A
Parent-offspring .5000 184 219 52
Sibs .5000 334 150 49
Grandparent-grandchild .2500 48 76 4
Avuncularb .2500 324 322 44
Half-sibs .2500 53 17 6
Great-grandparent–grandchild .1250 12 1 )
Grand avuncular .1250 87 63 1
Half-avuncular .1250 22 49 3
First-cousins .1250 471 201 16
Great–grand avuncular .0625 3 ) )
Half–grand avuncular .0625 9 2 )
First cousins, once removed .0625 407 118 )
Half–first cousins .0625 62 31 )
First cousins, twice removed .0312 9 ) )
Half–first cousins, once removed .0312 33 2 )
Second cousins .0312 213 33 )
Second cousins, once removed .0156 15 ) )
Total 2,286 1,284 175
a .2# Fij
b Includes all aunt/uncle-niece/nephew combinations.
The Mexican American population, a genetically ad-
mixed group with both Native American and white
ancestry, exhibits higher incidence of type 2 diabetes
than is seen in the general population of the United
States, and this excess incidence is thought to be related
to their Native American ancestry (Weiss et al. 1984;
Diehl and Stern 1989). In the present study, we utilized
a multipoint variance-components approach to scan the
genome for type 2 diabetes–susceptibility genes in a low-
income Mexican American population, using data from
440 individuals distributed across 27 extended pedi-
grees. This method is less penetrance-model dependent
than the classical segregation/linkage-mapping tech-
nique. Our genomewide scan for type 2 diabe-
tes–susceptibility genes used two phenotypes: type 2 di-
abetes (a dichotomous trait) and age at onset of type 2
diabetes (a truncated quantitative trait). Genotypic in-
formation from 379 microsatellite markers across the
genome was used in the linkage analyses.
Subjects and Methods
Subjects
Probands for the San Antonio Family Diabetes Study
(SAFADS) were type 2 diabetics identified in an earli-
er epidemiological survey, the San Antonio Heart Study,
which has been extensively described in previous
publications (Stern et al. 1984; Stern and Haffner 1990).
In brief, only low-income Mexican Americans identified
in the San Antonio Heart Study as having type 2 diabetes
were eligible to be probands. All first-, second-, and
third-degree relatives, ages 18–98 years, were invited to
participate in the study. In total, 579 individuals (140
diabetics) were examined, who were distributed across
32 extended families. The family-size range was 2–53
individuals (median family size 14 individuals). Meta-
bolic, anthropometric, and demographic data plus
medical histories were obtained on all the examined in-
dividuals. All procedures were approved by the Insti-
tutional Review Board of the University of Texas Health
Science Center at San Antonio, and all subjects gave
informed consent.
Blood samples were obtained after a 12-h fast for
assessment of various metabolic traits, including plasma
glucose levels. Glucose levels were also measured 2 h
after a standardized oral glucose load. Glucose levels
were measured by means of an Abbott Biochromatic
Analyzer. Diabetes was diagnosed according to World
Health Organization criteria ( World Health Organi-
zation Expert Committee 1985). Subjects who did not
meet these criteria but who gave a history of diabetes
and who reported that they were under treatment with
oral antidiabetic agents or insulin were also considered
to have diabetes.
A systematic genomewide search for type 2 diabe-
tes–susceptibility genes was performed on a subset of
440 participants in the 27 most informative extended
families. Of the 440 individuals, 116 are diabetics (in-
cluding probands), giving a prevalence of 26.4%. There
are 3,745 relative pairs, with varying degrees of genetic
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Figure 1 Diabetes-free survival among the SAFADS participants distributed across 27 pedigrees
relationship (table 1). Of these pairs, 2,286 are un-
affected-unaffected (U-U) pairs, 1,284 are unaffected-
affected pairs (U-A), and 175 are affected-affected pairs
(A-A). When parent-offspring pairs (which are unin-
formative with respect to linkage) are excluded, the dis-
tribution of the three categories of relative pairs is as
follows: U-U 2,102; U-A 1,065; and A-A 123.
Of the 116 diabetics, 50 subjects (43%) were clinically
diagnosed at the time of their SAFADS examination. The
remaining 66 diabetics (57%) were diagnosed prior to
the study, and their age-at-onset information was based
on self-reporting. The mean age at onset for the 116
affecteds was years. The mean age at onset49.8 14.1
for the subjects diagnosed at the time of their SAFADS
examination was years, compared with53.1 16.2
years for subjects diagnosed prior to the47.3 11.8
study. The mean age of unaffecteds was 38.3 15.4
years. Figure 1 depicts the diabetes-free survival among
the SAFADS participants, as based on the Kaplan-Meier
method as implemented in the SAS computer program
(Cantor 1997).
Genotyping
The identity of each marker tested and the LOD scores
(both two-point and multipoint) estimated can be found
at our Website (MARS). For the multipoint analyses,
markers with !∼80% of the sample genotyped were not
used unless their absence would result in a gap of 20
cM. Thus, a subset of 295 markers was selected on the
basis of optimal spacing and informativeness. Primers
were purchased from Research Genetics. Further details
concerning oligonucleotide-primer sequences and poly-
morphisms can be obtained from the Genome Database
at Johns Hopkins University (Fasman et al. 1996). PCR
conditions were optimized by testing a range of an-
nealing temperatures with varying concentrations of
MgCl2 (1.0, 1.5, 2.0, 2.5, 3.0, 3.5 or 4.0 mM), so that
the PCR amplification produced a specific product that
could be visualized by ethidium bromide staining (0.5
mg/ml).
Genotypes were collected primarily by PCR assays
with radiolabeled oligonucleotide primers. The antisense
primer was 5′-radiolabeled, in a standard polynucleotide
kinase reaction, with 3,000 Ci/mmol [g32P]-ATP (NEN)
at a molar ratio of 18 [g32P]-ATP:1 primer, as described
elsewhere (O’Connell et al. 1995; Duggirala et al. 1996).
Thirty cycles of PCR (denaturing at 94C for 30 s, an-
nealing at 55C for 1 min, and extension at 72C for 1
min) were performed in a 15-ml assay containing 50 ng
of DNA template, 10 mM Tris-HCl (pH 8.3), 50 mM
KCl, 1–4 mM MgCl2, 0.1 M spermidine (Sigma) 0.1 mM
of each PCR primer, 0.1 mM of each dNTP (Gibco BRL),
and 0.5 units of Taq polymerase (Perkin Elmer). Am-
plified DNA was diluted 1:1 with stop solution (97%
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formamide, 1% EDTA, 0.1% bromophenol blue, and
0.1% xylene cyanol) and was denatured at 85C for 2
min. Three microliters of denatured DNA from each
sample were loaded onto a 7% denaturing polyacryl-
amide gel (19:1 acrylamide/bis-acrylamide) containing
32% formamide and 34% urea and were fractionated
by gel electrophoresis for 2.5 h at 60 W. Gels were trans-
ferred to filter paper (Whatman 3MM; WR Balston)
covered with plastic wrap, were equilibrated with 20%
methanol/20% acetic acid solution, and were dried.
Dried gels were exposed to X-ray film (Fuji Photo Film).
Data for a subset (65) of the markers were collected by
use of fluorescently labeled primers purchased from Re-
search Genetics; these were PCR amplified as described
above and were loaded onto an Applied Biosystems
Model 373 sequencer, and the data were analyzed by
Applied Biosystems GENOTYPER software.
The genotypic data were entered into a database and
were analyzed for discrepancies (i.e., violations of Men-
delian inheritance), by the program INFER (Dyke 1996).
In the laboratory, discrepancies were checked for mis-
typing, and markers for discrepant individuals were
either corrected or blanked out prior to analysis. Our
genomewide screen currently provides coverage at
10–20-cM intervals on chromosomes 1–22.
Statistical Genetic Analyses
We used a multipoint variance-components procedure
to test for linkage between marker loci and two phe-
notypes: type 2 diabetes (a dichotomous trait) and age
at onset of diabetes (a quantitative trait). This technique,
originally developed for quantitative traits (Blangero and
Almasy 1997; Comuzzie et al. 1997), has recently been
extended to dichotomous-trait linkage analysis using a
threshold model (Duggirala et al. 1997). We have now
modified this procedure to allow for truncated traits,
such as age at onset.
The threshold model assumes that an individual be-
longs to a specific disease category if an underlying ge-
netically determined risk or liability exceeds a certain
threshold, T, on a normally distributed liability curve.
The liability is assumed to have an underlying multi-
variate-normal distribution. The correlation between
pairs of individuals is estimated on the basis of the af-
fection status of unrelated individuals and various clas-
ses of relatives. For a simple model, the liability corre-
lation (r) between individuals i and j is given by r ij
, where pmij is the proportion of
2 2 2p h  2F h  I emij m ij ij
genes that individuals i and j share identical by decent
(IBD) at a marker, m, linked to a quantitative-trait locus
(QTL); is the heritability attributed to the marker2hm
locus linked to a QTL; Fij is the kinship coefficient for
individuals i and j; h2 is the heritability attributed to
additive polygenic effects; Iij is the coefficient for the
random environmental component for individuals i and
j, which equals 1 if and 0 for all ; and 2i  j i( j e 
). Since calculation of the likelihood for this2 21 (h  hm
multifactorial model requires high-dimensional integra-
tion, we evaluated it approximately, using the Mendell/
Elston algorithm (Mendell and Elston 1974). The var-
iance-components and covariate effects for type 2 dia-
betes (i.e., sex and sex-specific age effects) are estimated,
simultaneously, by maximum-likelihood techniques.
In contrast to the threshold model described above,
in which age is incorporated as a covariate, the age-at-
onset analysis dissects the actual trait: age at onset of
diabetes. In this model, we allow age at onset to be
known or right-truncated in diabetics (i.e., in affected
subjects, age at onset of diabetes is less than or equal to
age at examination) and to be left-truncated in nondi-
abetics (i.e., in unaffected subjects, age at onset is greater
than age at examination). It is assumed that all individ-
uals are susceptible to type 2 diabetes and would ulti-
mately be affected if they lived long enough. This is a
reasonable assumption for common adult-onset diseases
that are related to physiological dysfunction. In fact, the
diabetes-free survival patterns among the SAFADS par-
ticipants (fig. 1) justify this assumption. The age at onset
(for the diabetics) and age at examination (for the non-
diabetics) determine the interval of integration, thus
leading to an integration problem very similar to that
in the purely discrete-trait case.
For the age-at-onset analysis, the variance components
are estimated together with the phenotypic mean, the
phenotypic SD, and sex as a covariate. Since the SAFADS
families were ascertained on the basis of type 2 diabetic
probands, our analyses included ascertainment correc-
tion. We corrected for the ascertainment by conditioning
on the likelihood of observing the diabetic condition of
the proband (Cannings and Thompson 1977). The hy-
pothesis tests are performed by likelihood-ratio tests.
The hypothesis of no linkage is tested by comparison of
the likelihood in a model in which the parameter is2hm
constrained to a value of 0 versus the likelihood in a
model in which the same parameter is estimated. Twice
the difference in ln likelihoods of these models yields a
test statistic that is asymptotically distributed, approx-
imating a x2 distribution (in fact, as a mixture of a1 1:2 2
and a point mass at 0 [Self and Liang 1987]). The2x1
df are equal to the difference in the number of param-
eters estimated in the two competing models. LOD
scores are obtained by conversion of the ln-likelihood
values into values of log to the base 10.
Locus-specific IBD information for pairs of relatives
in SAFADS families were obtained by an exact recursive
algorithm (Davis et al. 1996), by the program IBDMAT.
The multipoint mapping strategy proposed by Fulker et
al. (1995) has been extended and modified (Blangero
and Almasy 1997; Almasy and Blangero 1998) to per-
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Figure 2 Linkage of type 2 diabetes and age at onset of diabetes to a genetic location near the microsatellite marker D10S587 on
chromosome 10q.
form the multipoint variance-components analysis. Since
the method requires the distances between the markers
to be known, the order of loci spanning a given chro-
mosome and the maximum-likelihood sex-averaged map
distances between the marker loci were obtained by Ko-
sambi’s mapping function, by the program CRI-MAP
(Green et al. 1990), supplemented by the map infor-
mation in the Genome Database (Fasman et al. 1994,
1996) and Genetic Location Database (Collins et al.
1996). For each chromosome, a two-point variance-
components method is applied at 1-cM intervals. The
multipoint variance-components procedure for both dis-
crete and truncated quantitative traits has been imple-
mented in the computer program SOLAR (Almasy and
Blangero 1998).
Results
Prior to the linkage analyses, for the both type 2 di-
abetes phenotype and the age at onset of type 2 diabetes
phenotype, we first quantified the respective proportions
of variance that were attributable to additive genetic
factors (h2). After correcting for the effects of sex and
sex-specific age effects, we detected high heritability for
type 2 diabetes ( ), which was statisti-53.0% 17.2%
cally highly significant ( ). Individual specificP ! .0001
random environmental factors account for 47.0%
of variation. The heritability for age at onset of17.2%
diabetes was also high ( ) and statisti-45.5% 15.8%
cally significant ( ), and random environmentalP  .0001
effects contribute of total variation for54.5% 15.8%
this phenotype. Thus, additive genetic factors alone ex-
plain much of the phenotypic variation of both type 2
diabetes and age at onset of diabetes.
The linkage results reported here refer to the multi-
point variance-components linkage analyses only, and
all LOD scores are multipoint LOD scores. Overall, both
phenotypes exhibited similar linkage profiles across the
genome (Appendix). To determine whether our results
are robust to transformation, we repeated the analyses,
using log-transformed age-at-onset data. The resultant
LOD scores were almost identical to those obtained from
the untransformed data. We have elected to present the
results by using the untransformed age-at-onset analyses
in the present study. The highest LOD score was 3.75,
between a genetic location near the marker D10S587
on chromosome 10 and age at onset of type 2 diabetes.
This susceptibility locus, which is ∼1 cM telomeric to
the marker D10S587, explains (63.8% 9.9% P 
) of the total phenotypic variation in age at onset.000016
of diabetes. The discrete trait, diabetes, is also linked to
the same genetic location (LOD score 2.88), and this
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Table 2
Peak Multipoint LOD Scores at Genetic Locations with the
Nearest Flanking Markers on Chromosomes 3, 4, 9, and 10
MARKER REGION
MAP
POSITION
(cM)
PEAK MULTIPOINT
LOD SCORE FORa
Type 2
Diabetes
Age at Onset
of Diabetes
Chromosome 3:
D3S1566 59 ) )
Peak 70/71 2.67 (71 cM) 2.51 (70 cM)
GATA128C02 75 2.56 2.29
Chromosome 4:
D4S1615 170 1.94 )
Peak 172 1.99 )
D4S175 177 ) )
Chromosome 9:
D9S288 0 ) )
Peak 14/16 2.38 (16 cM) 2.06 (14 cM)
D9S925 26 ) )
Chromosome 10:
D10S587 145 2.87 3.73
Peak 146 2.88 3.75
D10S1223 155 2.07 2.87
a Only values 1.9 are shown (as suggested by Lander and
Kruglyak [1959]; see text).
putative locus accounts for (65.7% 10.9% P 
) of the total variation in liability to type 2 di-.000135
abetes. It should be noted that the trait-specific (i.e.,
diabetes and age at onset) additive genetic variance ex-
plained by this susceptibility locus is greater than the
additive genetic variance attributable to polygenic ef-
fects. The likely explanation for this apparent anomaly
is that the estimation of additive genetic variance at-
tributable to polygenic effects may be biased when, as
suggested by our data, major-gene effects are present.
The LOD scores obtained for both the diabetes anal-
ysis and the age-at-onset-of-diabetes analysis were plot-
ted against map positions on chromosome 10 (fig. 2).
As can be seen in figure 2, the two analyses yielded
similar topologies of likelihood function, for localiza-
tion of the susceptibility locus near the marker D10S587.
The highest LOD scores for both phenotypes occur near
the marker D10S587, but the respective peaks are rel-
atively broad. Specifically, the three sequential markers
D10S1230, D10S209, and D10S587 (which cover an
∼8-cM region) in this chromosomal region exhibit rel-
atively strong linkage with both phenotypes: age at onset
of diabetes (LOD scores: D10S1230, 3.36; D10S209,
3.48; and D10S587, 3.73) and diabetes (LOD scores:
D10S1230, 2.65; D10S209, 2.76; and D10S587, 2.87).
Both phenotypes peak at the same genetic location (∼1
cM telomeric to the marker D10S587), with the highest
LOD scores (diabetes, 2.88; and age at onset of diabetes,
3.75) (table 2).
The following chromosomal regions (table 2) show
suggestive linkage (i.e., multipoint LOD score 1.9) to
age at onset of diabetes: a genetic location near the
marker GATA128C02, on chromosome 3 (LOD score
2.51), and a location on chromosome 9, between the
markers D9S288 and D9S925 (LOD score 2.06). The
genetic location on chromosome 3 (near the marker
GATA128C02) is also statistically linked with type 2
diabetes, with a LOD score of 2.67. Two other chro-
mosomal regions that have suggestive linkages with type
2 diabetes are a location between the markers D9S288
and D9S925 (LOD score 2.38) on chromosome 9 and
a location between markers D4S1615 and D4S175 on
chromosome 4 (LOD score 1.99). No other multipoint
LOD scores 1.9 were observed.
Discussion
Type 2 diabetes continues to be a leading cause of
morbidity and mortality, especially in the developed
countries. Despite the belief that type 2 diabetes is under
genetic control and that it results from complex net-
works of gene(s) # environment interactions, little is
known about the chromosomal locations harboring type
2 diabetes–susceptibility genes. In recent years, suscep-
tibility genes for monogenic forms of type 2 diabetes
(i.e., maturity-onset diabetes of the young [MODY])
have been successfully mapped and, in some cases, iden-
tified. MODY1 has been localized to a region on chro-
mosome 20q (Bell et al. 1991); MODY2 has been linked
to the glucokinase locus on chromosome 7p (Frougel et
al. 1992); and MODY3 has been localized to a region
on chromosome 12q (Vaxillaire et al. 1995). As reviewed
by Elbein (1997), the genes responsible for these MODY
variants have been identified as follows: hepatocyte nu-
clear-transcription factor 4a for MODY1, glucokinase
for MODY2, and hepatocyte nuclear-transcription fac-
tor 1a for MODY3. The genetic basis of the common
form of type 2 diabetes, however, continues to be elusive.
In the present study, we found evidence for significant
linkage of age at onset of diabetes to a chromosomal
region on chromosome 10q, which appears to have sub-
stantial influence on both the age-at-onset-of-diabetes
phenotype and the type 2 diabetes phenotype.
Using a “candidate gene approach,” numerous studies
have examined whether genes involved in the pathways
of either insulin secretion or insulin action could influ-
ence susceptibility to the common form of type 2 dia-
betes. Thus far, however, none of these candidate gene
has consistently been found to play a substantial role in
the pathogenesis of type 2 diabetes (Elbein 1997). In
part, inconsistencies across the studies may be due either
to the heterogeneous nature of type 2 diabetes or to the
limitations of the various strategies for detection of link-
age (e.g., problems of model misspecification, which are
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associated with classical segregation/linkage analysis)
(McCarthy et al. 1994; Ghosh and Schork 1996).
Recently, two type 2 diabetes–susceptibility loci have
been reported by two groups, using genomewide scans,
who have designated them as “NIDDM1” (Hanis et al.
1996) and “NIDDM2” (Mahtani et al. 1996). Using the
data on Mexican American affected sib pairs from Starr
County, Texas, Hanis et al. (1996) found evidence for
linkage of type 2 diabetes to the telomeric region of
chromosome 2q (D2S125). However, this finding has not
been replicated in other studies (Elbein 1997; Mahtani
et al. 1996; McCarthy et al. 1997), including the present
study. Likewise, Hani et al. (1997b) failed to find evi-
dence for linkage between D2S125 and type 2 diabetes
in French families; but they found some evidence for
linkage between type 2 diabetes and the marker D2S140,
which is located 3 cM from D2S125. However, their
results became nonsignificant when a multipoint ap-
proach was used with weighting for nonindependent sib
pairs.
Mahtani et al. (1996) reported linkage of an insulin-
deficient form of type 2 diabetes to a location near
marker D12S1349 on chromosome 12q. In fact, they
were able to find evidence for linkage of this suscepti-
bility locus, NIDDM2, to type 2 diabetes only in a subset
(25%) of the original 26 families from the Bothnia re-
gion of western Finland. This chromosomal region con-
tains the MODY3 locus. Given that NIDDM2 appears
to be linked to a distinct form of type 2 diabetes asso-
ciated with low insulin secretion, no evidence for linkage
of this region to the common form of type 2 diabetes
has been found, thus far, in other studies (Elbein 1997),
including the present study. Recently, the report by Mah-
tani et al. (1996) has been clarified, on statistical
grounds, by Kong et al. (1997). According to the latter,
the NIDDM2 linkage result fails to “meet criteria for
genome-wide significance for an anonymous locus”
(Kong et al. (1997, p. 148). We also failed to replicate
the suggestive linkages, reported by Hanson et al.
(1997), between diabetes and regions on chromosomes
1 (1q21-23), 7 (7q21-22), and 11 (11q23-25). Neither
the studies described above nor two other studies in-
volving the Mexican American population (Mitchell et
al. 1998; Sakul et al. 1998) have reported evidence for
linkage of diabetes to the chromosome 10q region im-
plicated in the present study. It is worth noting, however,
that a recent genomewide scan for type 1 diabetes in a
large Bedouin Arab family has provided evidence for a
diabetes-susceptibility locus that maps to chromosome
10q25 (Verge et al. 1998), the region of interest in the
present study.
We have previously reported evidence for linkage
of 2-h plasma-glucose levels to a genetic location
(D11S899/D11S1324) on chromosome 11p, near the b-
cell high-affinity sulfonylurea receptor 1 (SUR1) locus
(Stern et al. 1996a). SUR1 plays an important role in
glucose-induced insulin secretion, and point mutations
of the SUR1 gene have been found in subjects with fa-
milial persistent hyperinsulinemic hypoglycemia of in-
fancy, a disorder of unregulated insulin secretion asso-
ciated with severe neonatal hypoglycemia (Thomas et al.
1995; Nestorowicz et al. 1996). In the present analysis,
the D11S899/D11S1324 region is weakly linked to both
the age-at-onset-of-diabetes phenotype (LOD score
0.85) and the diabetes phenotype (LOD score 0.86).
There is some evidence of association between two poly-
morphisms of the SUR1 gene and type 2 diabetes in
whites (Inoue et al. 1996; Hani et al. 1997a). Several
studies, however, have concluded that the SUR1 locus
is not a major determinant of type 2 diabetes in popu-
lations such as whites (Linder et al. 1997), Japanese
(Ohta et al. 1998), and Mexican Americans (Stirling et
al. 1995).
In the chromosome 10q region where the strongest
evidence for our linkage signal was found, there is no
known candidate gene for susceptibility to type 2 dia-
betes. Neither do the genetic locations on chromosomes
3 and 9, where suggestive linkages were found, contain
any known candidate genes for diabetes. In a recent
genomewide scan for diabetes-susceptibility genes in an-
other Mexican American population, a region on chro-
mosome 3p (3p21.1-21.3) has been shown to contain a
diabetes-susceptibility gene (LOD score 2.6) (Sakul et al.
1998). One of the chromosomal regions of interest in
the present study is also on chromosome 3p; however,
it is centromeric to the region 3p21.1-21.3. Elbein et
al. (1997) have found significant evidence for linkage of
fasting glucose level to a genetic location on chromo-
some 9p (LOD score 3.95), 13 cM from 9p-ter. This
region was linked neither to type 2 diabetes nor to
postchallenge glucose concentrations. However, it
should be noted that the chromosome 9p genetic loca-
tion of interest in the present study is ∼15 cM from 9p-
ter. The suggestive linkage of a location near the markers
D4S1615 and D4S175 to type 2 diabetes may implicate
intestinal fatty acid–binding protein, which has been
shown to be both associated with insulin resistance in
Pima Indians (Baier et al. 1995) and linked to 2-h insulin
concentrations in Mexican American families (Mitchell
et al. 1995).
Since genomewide scans for linkage involving com-
plex disease phenotypes may pose the problem of false-
positive results, several suggestions have been made by
various researchers to verify claims of linkage. For ex-
ample, Lander and Kruglyak (1995), in reference to the
allele-sharing methods, proposed the term “significant
linkage” to refer to LOD scores for various categories
of relative pairs approximately in the range 3.3–3.8 and
proposed the term “suggestive linkage” for LOD scores
approximately in the range 1.9–2.4. According to Ter-
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williger et al. (1997), “true” peaks appear to be relatively
longer, and such “longer” peaks are more likely to har-
bor a susceptibility gene than are “shorter” peaks. The
longer peaks may be indicative of the patterns of cor-
relation between the adjacent marker loci shared IBD
between relatives with linkage to a susceptibility locus.
Our findings on chromosome 10q correspond to (a) a
significant linkage between a genetic location near the
marker D10S587 and age at onset of type 2 diabetes
and (b) a suggestive linkage between the same chro-
mosomal location and type 2 diabetes itself. Further-
more, both the diabetes analysis and the age-at-onset-
of-diabetes analysis yielded similar linkage profiles,
involving longer peaks.
Data simulations have demonstrated that extended
pedigree–based multipoint variance-components ap-
proaches have greater power to detect linkages than do
nuclear family–based approaches, especially for quan-
titative traits (Williams et al. 1997; Duggirala et al.
1997; Almasy et al. 1997). Such increased power may
be partly due to the additional meioses available in ex-
tended pedigrees and to the increased ability to deter-
mine marker phase (Wijsman and Amos 1997). Aside
from relative efficiency (Greenberg et al. 1996, 1997;
Farrall 1997; Elston 1998), the extended pedigree–based
multipoint variance-components approach differs from
the commonly used affected-sib-pair methods, in the fol-
lowing ways. The variance-components approach uses
information not only from the affected relative pairs but
also from the unaffected and discordant relative pairs
across generations in complex pedigrees. After the effects
of age have been taken into account, as has been done
in our discrete-trait analysis, the unaffected individuals
provide valuable information for linkage; in particular,
the older they are, the more linkage information they
provide. With regard to age at onset, information from
increasingly distant relative pairs (e.g., first cousins) may,
relative to sib pairs, reduce the problem of possible co-
hort effects on onset times and may provide increased
power to detect linkage. Although age-at-onset infor-
mation obtained through self-report may be imprecise,
the colocalization of the peaks for both the diabetes
phenotype and the age-at-onset-of-diabetes phenotype is
reassuring.
The lack of replicability of initial linkage claims by
various research groups is of concern. If it can be as-
sumed that these claims are not false positives, then the
discrepant results across the studies imply substantial
genetic heterogeneity underlying the phenotypic expres-
sion of type 2 diabetes in diverse ethnic groups. It is
possible that the common form of type 2 diabetes is truly
oligogenic, with loci having differential effect sizes, and
that some forms of diabetes may indeed be caused by
genes that are rare but that have appreciable effects.
Also, replication of a true linkage in a disease with ol-
igogenic inheritance is difficult because it is likely to
require a larger number of families than is required for
the initial detection (Suarez et al. 1994). This is because
the fortuitous circumstances that led to detection of the
linkage in the original set of families may not be repli-
cated for oligogenic traits unless many more families are
examined in the replication effort.
In conclusion, by conducting a genomewide scan for
type 2 diabetes–susceptibility genes in a Mexican Amer-
ican population, we have found the strongest evidence
for linkage, both to age at onset of diabetes and to type
2 diabetes itself, at a genetic location on chromosome
10q. This susceptibility locus appears to have substantial
influence on the phenotypic variation of both type 2
diabetes and age at onset of type 2 diabetes. Since there
are no candidate genes in this region, positional cloning
efforts would be required to identify a diabetes-suscep-
tibility gene. Confirmation of our results in other pop-
ulations would strengthen the argument for undertaking
such a positional cloning project.
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